Nimuson Plus (100+500) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Materkin Formulation (Symbiosis Pharmaceuticals Pvt Ltd). This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Paracetamol, Nimesulide. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 29 (arround $0.406 US Dollar)
The main active ingredients or salts in Nimuson Plus (100+500) are :
Paracetamol-500 mg
Nimesulide-100 mg
Paracetamol Indication (Prescribed for or used as): Analgesic and antipyretic.
For more details on Paracetamol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Paracetamol..
Nimesulide Indication (Prescribed for or used as): Analgesic and antipyretic. Rheumatoid arthritis, osteoarthritis, other degenerative joint disorders. Musculo skeletal disorders. Thrombophlebitis.
For more details on Nimesulide, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Nimesulide..
Nimuson Plus (100+500) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 548 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Nimuson Plus (100+500), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Paracetamol-500 mg Nimesulide-100 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.
Nimuson Plus (100+500) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Materkin Formulation (Symbiosis Pharmaceuticals Pvt Ltd). This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Nimesulide, Paracetamol. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 29 (arround $0.406 US Dollar)
The main active ingredients or salts in Nimuson Plus (100+500) are :
Nimesulide-100 mg
Paracetamol-500 mg
Nimesulide Indication (Prescribed for or used as): Analgesic and antipyretic. Rheumatoid arthritis, osteoarthritis, other degenerative joint disorders. Musculo skeletal disorders. Thrombophlebitis.
For more details on Nimesulide, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Nimesulide..
Paracetamol Indication (Prescribed for or used as): Analgesic and antipyretic.
For more details on Paracetamol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Paracetamol..
Nimuson Plus (100+500) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 85 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Nimuson Plus (100+500), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Nimesulide-100 mg Paracetamol-500 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.